Techno Medica Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Masatomo Saneyoshi

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	10yrs
Participación del CEO	2.8%
Permanencia media de la dirección	8yrs
Promedio de permanencia en la Junta Directiva	7yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Masatomo Saneyoshi (51 yo)

10yrs

Permanencia

Mr. Masatomo Saneyoshi has been the President of Techno Medica Co., Ltd., since June 2014 and serves as its Chief Executive Officer. Mr. Saneyoshi served as Assistant to The President at Techno Medica Co....

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Masatomo Saneyoshi	President	10yrs	sin datos	2.85% ¥ 348.3m
Masato Takeda	GM of Sales Headquarters & Director	7.8yrs	sin datos	0.18% ¥ 22.5m
Kazuto Tsugawa	GM of Business Management Headquarters & Business Planning Office and Director	6yrs	sin datos	0.097% ¥ 11.9m
Yasushi Nakano	GM of Medical Solutions Development Department	8.2yrs	sin datos	0.080% ¥ 9.7m

8.0yrs

Permanencia media

58.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 6678 es experimentado (7.8 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Masatomo Saneyoshi	President	15yrs	sin datos	2.85% ¥ 348.3m
Masato Takeda	GM of Sales Headquarters & Director	15yrs	sin datos	0.18% ¥ 22.5m
Kazuto Tsugawa	GM of Business Management Headquarters & Business Planning Office and Director	7yrs	sin datos	0.097% ¥ 11.9m
Yasushi Nakano	GM of Medical Solutions Development Department	5yrs	sin datos	0.080% ¥ 9.7m
Yosuke Yasukata	Independent External Director	7.8yrs	sin datos	0.027% ¥ 3.4m
Shinichi Matsuo	Independent Outside Director	6yrs	sin datos	0.022% ¥ 2.7m
Jun Ozeki	Independent Outside Director	7yrs	sin datos	0.023% ¥ 2.8m

7.0yrs

Permanencia media

67yo

Promedio de edad

Junta con experiencia: La junta directiva de 6678 se considera experimentada (6.8 años de antigüedad promedio).

Techno Medica Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Techno Medica Co., Ltd., Annual General Meeting, Jun 26, 2024

Techno Medica Co., Ltd., Annual General Meeting, Jun 28, 2023

Less than half of directors are independent

Recent updates

Full year 2024 earnings released: EPS: JP¥173 (vs JP¥136 in FY 2023)

Techno Medica Co., Ltd., Annual General Meeting, Jun 26, 2024

Techno Medica Co., Ltd. Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 27, 2024

Upcoming dividend of JP¥55.00 per share

Techno Medica Co., Ltd. to Report Fiscal Year 2024 Results on May 09, 2024

Third quarter 2024 earnings released: EPS: JP¥34.20 (vs JP¥30.09 in 3Q 2023)

Techno Medica Co., Ltd. (TSE:6678) announces an Equity Buyback for 1,220,000 shares, representing 15.08% for ¥2,836.5 million.

Second quarter 2024 earnings released: EPS: JP¥37.61 (vs JP¥26.35 in 2Q 2023)

First quarter 2024 earnings released: EPS: JP¥8.73 (vs JP¥10.33 in 1Q 2023)

Techno Medica Co., Ltd. Announces Dividend for the Year Ended March 31, 2023, Payable on June 29, 2023

Techno Medica Co., Ltd. (TSE:6678) announces an Equity Buyback for 400,000 shares, for ¥724.4 million.

Full year 2023 earnings released: EPS: JP¥136 (vs JP¥151 in FY 2022)

Techno Medica Co., Ltd., Annual General Meeting, Jun 28, 2023

Upcoming dividend of JP¥55.00 per share at 2.8% yield

Third quarter 2023 earnings released: EPS: JP¥30.09 (vs JP¥24.11 in 3Q 2022)

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥26.35 (vs JP¥34.86 in 2Q 2022)

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

First quarter 2023 earnings released: EPS: JP¥10.33 (vs JP¥20.07 in 1Q 2022)

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Full year 2022 earnings released: EPS: JP¥151 (vs JP¥136 in FY 2021)

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2023

Techno Medica Co., Ltd. to Report Q3, 2023 Results on Feb 01, 2023

Upcoming dividend of JP¥51.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Techno Medica Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2022

Second quarter 2022 earnings released: EPS JP¥34.86 (vs JP¥26.17 in 2Q 2021)

First quarter 2022 earnings released: EPS JP¥20.07 (vs JP¥6.96 in 1Q 2021)

Full year 2021 earnings released: EPS JP¥136 (vs JP¥118 in FY 2020)

Inaugural dividend of JP¥49.00 per share

Techno Medica Co., Ltd. to Report Fiscal Year 2021 Results on May 12, 2021

New 90-day high: JP¥1,647

Third quarter 2021 earnings released: EPS JP¥31.67 (vs JP¥20.99 in 3Q 2020)

New 90-day low: JP¥1,488

Techno Medica Co., Ltd. to Report Q2, 2021 Results on Nov 04, 2020

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad